Evaluation of the efficacy of a combination of diltiazem and periprostatic nerve block in pain control during transrectal ultrasound guided biopsy of the prostate
Not Applicable
Completed
- Conditions
- Health Condition 1: null- clinical or biochemical suspicion of prostate carcinoma
- Registration Number
- CTRI/2012/09/003027
- Lead Sponsor
- Dr Tarun Jindal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
The patients who were to have their first prostatic biopsy due to clinical or biochemical suspicion of carcinoma prostate were included in the trial.
Exclusion Criteria
history of active anal diseases, anal fissures, haemorrhoids, rectal ulcers, chronic pelvic pain syndrome, prostodynia, active urinary tract infection, coagulopathies, neuropathies, uncontrolled diabetes, ingestion of asprin or clopidogril or any other antiplatelet drugs, use of narcotics and analgesics, antihypertensive medications, known allergy to diltiazem or lignocaine, low systolic blood pressure ( <100 mm Hg), severe renal, cardiac or hepatic illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method